Listed

Enveric Biosciences, Inc.: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Nov 6, 2013 and accepted by EDGAR at Nov 6, 2013, 13:12 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2013-07-01 to 2013-09-30−$4.6kus-gaap:OperatingIncomeLoss
Operating income9 months2013-01-01 to 2013-09-30−$13.1kus-gaap:OperatingIncomeLoss
Income tax3 months2013-07-01 to 2013-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-01-01 to 2013-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-07-01 to 2013-09-30−$4.6kus-gaap:NetIncomeLoss
Net income9 months2013-01-01 to 2013-09-30−$13.1kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-07-01 to 2013-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2013-01-01 to 2013-09-30−$21.2kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2013-09-30$684us-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-09-30$4.9kus-gaap:AssetsCurrent
Total assetsAt period end2013-09-30$4.9kus-gaap:Assets
Current liabilitiesAt period end2013-09-30$38.1kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2013-09-30−$33.2kus-gaap:StockholdersEquity
Shares outstandingAt period end2013-09-3012,142,000 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001477932-13-005130. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.